169 related articles for article (PubMed ID: 17537863)
1. Mn2+ suppressor mutations and biochemical communication between Ty1 reverse transcriptase and RNase H domains.
Yarrington RM; Chen J; Bolton EC; Boeke JD
J Virol; 2007 Sep; 81(17):9004-12. PubMed ID: 17537863
[TBL] [Abstract][Full Text] [Related]
2. Expression of an active form of recombinant Ty1 reverse transcriptase in Escherichia coli: a fusion protein containing the C-terminal region of the Ty1 integrase linked to the reverse transcriptase-RNase H domain exhibits polymerase and RNase H activities.
Wilhelm M; Boutabout M; Wilhelm FX
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):337-42. PubMed ID: 10816427
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of reverse transcription in vivo by elevated manganese ion concentration.
Bolton EC; Mildvan AS; Boeke JD
Mol Cell; 2002 Apr; 9(4):879-89. PubMed ID: 11983178
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.
Lim D; Orlova M; Goff SP
J Virol; 2002 Aug; 76(16):8360-73. PubMed ID: 12134040
[TBL] [Abstract][Full Text] [Related]
5. Role of integrase in reverse transcription of the Saccharomyces cerevisiae retrotransposon Ty1.
Wilhelm M; Wilhelm FX
Eukaryot Cell; 2005 Jun; 4(6):1057-65. PubMed ID: 15947198
[TBL] [Abstract][Full Text] [Related]
6. Polypurine tract formation by Ty1 RNase H.
Wilhelm M; Uzun O; Mules EH; Gabriel A; Wilhelm FX
J Biol Chem; 2001 Dec; 276(50):47695-701. PubMed ID: 11595735
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Moloney murine leukaemia virus/avian myeloblastosis virus chimeric reverse transcriptases.
Yasukawa K; Mizuno M; Inouye K
J Biochem; 2009 Mar; 145(3):315-24. PubMed ID: 19060310
[TBL] [Abstract][Full Text] [Related]
9. Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine.
Ntemgwa M; Wainberg MA; Oliveira M; Moisi D; Lalonde R; Micheli V; Brenner BG
Antimicrob Agents Chemother; 2007 Nov; 51(11):3861-9. PubMed ID: 17724152
[TBL] [Abstract][Full Text] [Related]
10. RNase H activity: structure, specificity, and function in reverse transcription.
Schultz SJ; Champoux JJ
Virus Res; 2008 Jun; 134(1-2):86-103. PubMed ID: 18261820
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase.
Boyer PL; Stenbak CR; Clark PK; Linial ML; Hughes SH
J Virol; 2004 Jun; 78(12):6112-21. PubMed ID: 15163704
[TBL] [Abstract][Full Text] [Related]
12. Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase.
Kirby KA; Marchand B; Ong YT; Ndongwe TP; Hachiya A; Michailidis E; Leslie MD; Sietsema DV; Fetterly TL; Dorst CA; Singh K; Wang Z; Parniak MA; Sarafianos SG
Antimicrob Agents Chemother; 2012 Apr; 56(4):2048-61. PubMed ID: 22252812
[TBL] [Abstract][Full Text] [Related]
13. A Ty1 reverse transcriptase active-site aspartate mutation blocks transposition but not polymerization.
Uzun O; Gabriel A
J Virol; 2001 Jul; 75(14):6337-47. PubMed ID: 11413300
[TBL] [Abstract][Full Text] [Related]
14. Phosphorothioate oligonucleotides block reverse transcription by the Rnase H activity associated with the HIV-1 polymerase.
Hatta T; Takai K; Yokoyama S; Nakashima H; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1995 Jun; 211(3):1041-6. PubMed ID: 7541196
[TBL] [Abstract][Full Text] [Related]
15. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
16. Substitution of a highly basic helix/loop sequence into the RNase H domain of human immunodeficiency virus reverse transcriptase restores its Mn(2+)-dependent RNase H activity.
Keck JL; Marqusee S
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2740-4. PubMed ID: 7535929
[TBL] [Abstract][Full Text] [Related]
17. RNA branching and debranching in the yeast retrovirus-like element Ty1.
Cheng Z; Menees TM
Science; 2004 Jan; 303(5655):240-3. PubMed ID: 14716018
[TBL] [Abstract][Full Text] [Related]
18. Ty1 reverse transcriptase does not read through the proposed 2',5'-branched retrotransposition intermediate in vitro.
Pratico ED; Silverman SK
RNA; 2007 Sep; 13(9):1528-36. PubMed ID: 17652136
[TBL] [Abstract][Full Text] [Related]
19. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity.
Tisdale M; Schulze T; Larder BA; Moelling K
J Gen Virol; 1991 Jan; 72 ( Pt 1)():59-66. PubMed ID: 1703563
[TBL] [Abstract][Full Text] [Related]
20. Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.
Julias JG; Ferris AL; Boyer PL; Hughes SH
J Virol; 2001 Jul; 75(14):6537-46. PubMed ID: 11413321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
